2022 AADOCR/CADR Annunal Meeting
The 51st Annual Meeting of the AADOCR was held in conjunction with the 46th Annual Meeting of the Canadian Association for Dental Research, from March 14-26 as a hybrid experience with 839 individuals from 18 countries attending in person in Atlanta, GA and 692 individuals from 21 countries attending virtually.The recordings in this library from the meeting are a selection of the science that was to be presented as part of the Annual Meeting. These recordings give you the opportunity to participate in the meeting and hear from leading researchers. The recordings include IADR Distinguished Lecture Series speakers and symposia from a collection of scientific groups and networks.
This session can be purchased as part of the full meeting recordings within the product bundles
The International Association for Dental Research is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Session Description
In the United States (U.S.), the human papillomavirus (HPV) is the leading cause of oropharyngeal cancers (OPCs), leading to 70% of the OPCs diagnosed annually. According to the Centers for Disease Control and Prevention (CDC), each year approximately 3,500 women and 16,700 men are diagnosed with HPV-related OPCs. The HPV vaccine approved by the U.S. Food and Drug Administration (FDA) covers high-risk HPV types that have been linked to more than half of OPCs, yet according to the U.S. Department of Health and Human Services (HHS), fewer than half of individuals aged 18-26 had received at least one HPV vaccine dose, and only 22% had received the complete vaccination series. Oral healthcare providers are in a unique position to educate patients about the risks associated with HPV infection and the effectiveness of the HPV vaccine to prevent OPCs. This symposium will discuss findings related to HPV and OPCs from analyses of claims and NHANES data regarding early identification of OPCs and HPV vaccination education by oral healthcare providers. It will also include survey data from healthcare consumers about their knowledge regarding HPV and the HPV vaccine, and survey data from dental and medical providers regarding their perceived role in discussing risk factors and prevention of HPV-related OPCs with their patients. Panelists will discuss dental-medical collaboration opportunities to increase the rates of HPV vaccinations and improve knowledge of the link between HPV and OPC.
Learning Objectives
Presentation Date
March 23, 2022
Presenters
Scott Tomar - Big data analysis on the association between oral and oropharyngeal cancer screenings by dentists and malignant transformation
Megan Cloidt - Identifying the utility of dental providers in HPV prevention efforts: results from the National Health and Nutrition Examination Survey 2015-2018
Shillpa Naavaal - Knowledge and perceptions about HPV and the HPV vaccine: Opportunities to bridge knowledge gaps through trust in oral healthcare providers
Tracy Finlayson - Understanding healthcare provider perceptions around HPV-related oropharyngeal cancer patient engagement.
Sponsoring Groups/Networks
Behavioral, Epidemiologic, and Health Services Research, Oral Medicine & Pathology Research, Pediatric Oral Health Research, Women in Science Network
In the United States (U.S.), the human papillomavirus (HPV) is the leading cause of oropharyngeal cancers (OPCs), leading to 70% of the OPCs diagnosed annually. According to the Centers for Disease Control and Prevention (CDC), each year approximately 3,500 women and 16,700 men are diagnosed with HPV-related OPCs. The HPV vaccine approved by the U.S. Food and Drug Administration (FDA) covers high-risk HPV types that have been linked to more than half of OPCs, yet according to the U.S. Department of Health and Human Services (HHS), fewer than half of individuals aged 18-26 had received at least one HPV vaccine dose, and only 22% had received the complete vaccination series. Oral healthcare providers are in a unique position to educate patients about the risks associated with HPV infection and the effectiveness of the HPV vaccine to prevent OPCs. This symposium will discuss findings related to HPV and OPCs from analyses of claims and NHANES data regarding early identification of OPCs and HPV vaccination education by oral healthcare providers. It will also include survey data from healthcare consumers about their knowledge regarding HPV and the HPV vaccine, and survey data from dental and medical providers regarding their perceived role in discussing risk factors and prevention of HPV-related OPCs with their patients. Panelists will discuss dental-medical collaboration opportunities to increase the rates of HPV vaccinations and improve knowledge of the link between HPV and OPC.
Learning Objectives
- Describe the association between human papilloma virus (HPV) and oropharyngeal cancer (OPC) and the role of the HPV vaccine in cancer prevention.
- Discuss factors associated with knowledge of link between HPV and OPC and consequences for HPV vaccination uptake.
- Discuss the role of dental providers in a dental-medical integration for providing HPV education and vaccinations to patients.
Presentation Date
March 23, 2022
Presenters
Scott Tomar - Big data analysis on the association between oral and oropharyngeal cancer screenings by dentists and malignant transformation
Megan Cloidt - Identifying the utility of dental providers in HPV prevention efforts: results from the National Health and Nutrition Examination Survey 2015-2018
Shillpa Naavaal - Knowledge and perceptions about HPV and the HPV vaccine: Opportunities to bridge knowledge gaps through trust in oral healthcare providers
Tracy Finlayson - Understanding healthcare provider perceptions around HPV-related oropharyngeal cancer patient engagement.
Sponsoring Groups/Networks
Behavioral, Epidemiologic, and Health Services Research, Oral Medicine & Pathology Research, Pediatric Oral Health Research, Women in Science Network
CE Credits
1.5 Hours
Not eligible for individual purchase must purchase as part of a meeting bundle.
